Drug Shortage Report for TOBI
Report ID | 192953 |
Drug Identification Number | 02239630 |
Brand name | TOBI |
Common or Proper name | TOBRAMYCIN |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 300MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION INHALATION |
Packaging size | 56 AMPULES |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-06-01 |
Actual start date | 2023-05-31 |
Estimated end date | 2024-04-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v35 | 2024-04-16 | French | Compare |
v34 | 2024-04-16 | English | Compare |
v33 | 2024-03-25 | French | Compare |
v32 | 2024-03-25 | English | Compare |
v31 | 2024-03-12 | French | Compare |
v30 | 2024-03-12 | English | Compare |
v29 | 2024-02-21 | French | Compare |
v28 | 2024-02-21 | English | Compare |
v27 | 2024-02-15 | French | Compare |
v26 | 2024-02-15 | English | Compare |
v25 | 2024-01-22 | French | Compare |
v24 | 2024-01-22 | English | Compare |
v23 | 2023-12-19 | French | Compare |
v22 | 2023-12-19 | English | Compare |
v21 | 2023-12-12 | French | Compare |
v20 | 2023-12-12 | English | Compare |
v19 | 2023-11-06 | French | Compare |
v18 | 2023-11-06 | English | Compare |
v17 | 2023-10-17 | French | Compare |
v16 | 2023-10-17 | English | Compare |